nodes	percent_of_prediction	percent_of_DWPC	metapath
Bismuth Subsalicylate—PTGS2—Risedronate—osteoporosis	0.353	0.596	CbGbCtD
Bismuth Subsalicylate—ALB—Estropipate—osteoporosis	0.168	0.285	CbGbCtD
Bismuth Subsalicylate—ALB—Estradiol—osteoporosis	0.07	0.118	CbGbCtD
Bismuth Subsalicylate—TF—vertebral column—osteoporosis	0.0154	0.561	CbGeAlD
Bismuth Subsalicylate—PTGS2—periosteum—osteoporosis	0.00528	0.192	CbGeAlD
Bismuth Subsalicylate—TF—uterus—osteoporosis	0.00255	0.0926	CbGeAlD
Bismuth Subsalicylate—TF—bone marrow—osteoporosis	0.00216	0.0786	CbGeAlD
Bismuth Subsalicylate—Decreased appetite—Calcium Acetate—osteoporosis	0.00113	0.0049	CcSEcCtD
Bismuth Subsalicylate—Constipation—Calcium Acetate—osteoporosis	0.00111	0.00482	CcSEcCtD
Bismuth Subsalicylate—Pain—Calcium Acetate—osteoporosis	0.00111	0.00482	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Ergocalciferol—osteoporosis	0.00109	0.00475	CcSEcCtD
Bismuth Subsalicylate—Drowsiness—Calcitriol—osteoporosis	0.00108	0.00471	CcSEcCtD
Bismuth Subsalicylate—Abdominal pain upper—Risedronate—osteoporosis	0.00108	0.0047	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Calcium Acetate—osteoporosis	0.00107	0.00465	CcSEcCtD
Bismuth Subsalicylate—Lethargy—Zoledronate—osteoporosis	0.00105	0.00456	CcSEcCtD
Bismuth Subsalicylate—Erythema—Etidronic acid—osteoporosis	0.00104	0.00453	CcSEcCtD
Bismuth Subsalicylate—Skin exfoliation—Estradiol—osteoporosis	0.00104	0.00453	CcSEcCtD
Bismuth Subsalicylate—Asthma—Risedronate—osteoporosis	0.00102	0.00445	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Ergocalciferol—osteoporosis	0.000995	0.00433	CcSEcCtD
Bismuth Subsalicylate—Abdominal discomfort—Risedronate—osteoporosis	0.00098	0.00427	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Estropipate—osteoporosis	0.000979	0.00426	CcSEcCtD
Bismuth Subsalicylate—Pain—Ergocalciferol—osteoporosis	0.000978	0.00426	CcSEcCtD
Bismuth Subsalicylate—Constipation—Ergocalciferol—osteoporosis	0.000978	0.00426	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Alendronate—osteoporosis	0.000964	0.0042	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Ethinyl Estradiol—osteoporosis	0.000954	0.00415	CcSEcCtD
Bismuth Subsalicylate—Abdominal pain upper—Zoledronate—osteoporosis	0.000938	0.00408	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Calcitriol—osteoporosis	0.000919	0.004	CcSEcCtD
Bismuth Subsalicylate—Phlebitis—Estradiol—osteoporosis	0.000919	0.004	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Calcium Acetate—osteoporosis	0.000916	0.00399	CcSEcCtD
Bismuth Subsalicylate—Erythema—Estropipate—osteoporosis	0.000901	0.00392	CcSEcCtD
Bismuth Subsalicylate—Erythema—Alendronate—osteoporosis	0.000888	0.00386	CcSEcCtD
Bismuth Subsalicylate—Asthma—Zoledronate—osteoporosis	0.000888	0.00386	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Calcium Acetate—osteoporosis	0.000886	0.00386	CcSEcCtD
Bismuth Subsalicylate—Deafness—Estradiol—osteoporosis	0.000885	0.00385	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Alendronate—osteoporosis	0.000869	0.00378	CcSEcCtD
Bismuth Subsalicylate—Erythema—Ibandronate—osteoporosis	0.000864	0.00376	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Etidronic acid—osteoporosis	0.000857	0.00373	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Calcium Acetate—osteoporosis	0.000857	0.00373	CcSEcCtD
Bismuth Subsalicylate—Asthma—Conjugated Estrogens—osteoporosis	0.000855	0.00372	CcSEcCtD
Bismuth Subsalicylate—Abdominal discomfort—Zoledronate—osteoporosis	0.000851	0.0037	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Ibandronate—osteoporosis	0.000846	0.00368	CcSEcCtD
Bismuth Subsalicylate—Erythema—Calcitriol—osteoporosis	0.000846	0.00368	CcSEcCtD
Bismuth Subsalicylate—Infection—Etidronic acid—osteoporosis	0.000845	0.00368	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Calcitriol—osteoporosis	0.000829	0.00361	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Calcium Acetate—osteoporosis	0.000824	0.00358	CcSEcCtD
Bismuth Subsalicylate—Abdominal discomfort—Conjugated Estrogens—osteoporosis	0.000819	0.00357	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Zoledronate—osteoporosis	0.000808	0.00352	CcSEcCtD
Bismuth Subsalicylate—Lethargy—Estradiol—osteoporosis	0.000808	0.00352	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Ethinyl Estradiol—osteoporosis	0.000794	0.00345	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Conjugated Estrogens—osteoporosis	0.000778	0.00339	CcSEcCtD
Bismuth Subsalicylate—Nausea—Calcium Acetate—osteoporosis	0.000769	0.00335	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Risedronate—osteoporosis	0.000763	0.00332	CcSEcCtD
Bismuth Subsalicylate—PTGS1—uterus—osteoporosis	0.000755	0.0275	CbGeAlD
Bismuth Subsalicylate—Dyspepsia—Etidronic acid—osteoporosis	0.000749	0.00326	CcSEcCtD
Bismuth Subsalicylate—Oedema—Estropipate—osteoporosis	0.000736	0.0032	CcSEcCtD
Bismuth Subsalicylate—Infection—Estropipate—osteoporosis	0.000731	0.00318	CcSEcCtD
Bismuth Subsalicylate—Constipation—Etidronic acid—osteoporosis	0.000727	0.00316	CcSEcCtD
Bismuth Subsalicylate—Abdominal pain upper—Estradiol—osteoporosis	0.000723	0.00315	CcSEcCtD
Bismuth Subsalicylate—PTGS2—uterus—osteoporosis	0.000722	0.0262	CbGeAlD
Bismuth Subsalicylate—Infection—Alendronate—osteoporosis	0.00072	0.00313	CcSEcCtD
Bismuth Subsalicylate—Infection—Raloxifene—osteoporosis	0.000708	0.00308	CcSEcCtD
Bismuth Subsalicylate—Infection—Ibandronate—osteoporosis	0.000701	0.00305	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Etidronic acid—osteoporosis	0.000701	0.00305	CcSEcCtD
Bismuth Subsalicylate—Asthma—Estradiol—osteoporosis	0.000684	0.00298	CcSEcCtD
Bismuth Subsalicylate—Nausea—Ergocalciferol—osteoporosis	0.00068	0.00296	CcSEcCtD
Bismuth Subsalicylate—Erythema—Pamidronate—osteoporosis	0.000677	0.00295	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Etidronic acid—osteoporosis	0.000676	0.00294	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Pamidronate—osteoporosis	0.000663	0.00289	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Calcitriol—osteoporosis	0.000658	0.00286	CcSEcCtD
Bismuth Subsalicylate—Abdominal discomfort—Estradiol—osteoporosis	0.000656	0.00285	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Estropipate—osteoporosis	0.000654	0.00285	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Estropipate—osteoporosis	0.000648	0.00282	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Conjugated Estrogens—osteoporosis	0.000647	0.00282	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Alendronate—osteoporosis	0.000638	0.00278	CcSEcCtD
Bismuth Subsalicylate—ALB—Lipid and lipoprotein metabolism—P4HB—osteoporosis	0.000633	0.00418	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—TLN1—osteoporosis	0.000633	0.00417	CbGpPWpGaD
Bismuth Subsalicylate—Pain—Estropipate—osteoporosis	0.000629	0.00274	CcSEcCtD
Bismuth Subsalicylate—Constipation—Estropipate—osteoporosis	0.000629	0.00274	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Raloxifene—osteoporosis	0.000627	0.00273	CcSEcCtD
Bismuth Subsalicylate—TF—Hemostasis—VCL—osteoporosis	0.000624	0.00412	CbGpPWpGaD
Bismuth Subsalicylate—Weight increased—Estradiol—osteoporosis	0.000623	0.00271	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Ibandronate—osteoporosis	0.000621	0.0027	CcSEcCtD
Bismuth Subsalicylate—Pain—Alendronate—osteoporosis	0.00062	0.0027	CcSEcCtD
Bismuth Subsalicylate—Constipation—Alendronate—osteoporosis	0.00062	0.0027	CcSEcCtD
Bismuth Subsalicylate—Erythema—Zoledronate—osteoporosis	0.000619	0.00269	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Calcitriol—osteoporosis	0.000614	0.00267	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Ibandronate—osteoporosis	0.000613	0.00267	CcSEcCtD
Bismuth Subsalicylate—PTGS2—bone marrow—osteoporosis	0.000613	0.0223	CbGeAlD
Bismuth Subsalicylate—Pain—Raloxifene—osteoporosis	0.000609	0.00265	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Zoledronate—osteoporosis	0.000606	0.00264	CcSEcCtD
Bismuth Subsalicylate—Pain—Ibandronate—osteoporosis	0.000603	0.00263	CcSEcCtD
Bismuth Subsalicylate—Constipation—Ibandronate—osteoporosis	0.000603	0.00263	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Etidronic acid—osteoporosis	0.000602	0.00262	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Calcitriol—osteoporosis	0.0006	0.00261	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Alendronate—osteoporosis	0.000597	0.0026	CcSEcCtD
Bismuth Subsalicylate—Oedema—Ethinyl Estradiol—osteoporosis	0.000596	0.00259	CcSEcCtD
Bismuth Subsalicylate—Erythema—Conjugated Estrogens—osteoporosis	0.000596	0.00259	CcSEcCtD
Bismuth Subsalicylate—Infection—Ethinyl Estradiol—osteoporosis	0.000592	0.00258	CcSEcCtD
Bismuth Subsalicylate—Pain—Calcitriol—osteoporosis	0.000591	0.00257	CcSEcCtD
Bismuth Subsalicylate—Constipation—Calcitriol—osteoporosis	0.000591	0.00257	CcSEcCtD
Bismuth Subsalicylate—ALB—Platelet degranulation—PLEK—osteoporosis	0.000585	0.00386	CbGpPWpGaD
Bismuth Subsalicylate—Urticaria—Estropipate—osteoporosis	0.000584	0.00254	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Conjugated Estrogens—osteoporosis	0.000583	0.00254	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Etidronic acid—osteoporosis	0.000582	0.00253	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Estropipate—osteoporosis	0.000582	0.00253	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Ibandronate—osteoporosis	0.000581	0.00253	CcSEcCtD
Bismuth Subsalicylate—TF—Differentiation Pathway—IL6—osteoporosis	0.00058	0.00382	CbGpPWpGaD
Bismuth Subsalicylate—Infection—Risedronate—osteoporosis	0.000578	0.00251	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Alendronate—osteoporosis	0.000576	0.0025	CcSEcCtD
Bismuth Subsalicylate—Epistaxis—Estradiol—osteoporosis	0.000575	0.0025	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—ACP5—osteoporosis	0.000575	0.00379	CbGpPWpGaD
Bismuth Subsalicylate—Body temperature increased—Alendronate—osteoporosis	0.000573	0.00249	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Raloxifene—osteoporosis	0.000563	0.00245	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Ibandronate—osteoporosis	0.00056	0.00244	CcSEcCtD
Bismuth Subsalicylate—ALB—Binding and Uptake of Ligands by Scavenger Receptors—COL1A1—osteoporosis	0.00056	0.00369	CbGpPWpGaD
Bismuth Subsalicylate—Body temperature increased—Ibandronate—osteoporosis	0.000558	0.00243	CcSEcCtD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—PLEK—osteoporosis	0.000558	0.00368	CbGpPWpGaD
Bismuth Subsalicylate—Confusional state—Pamidronate—osteoporosis	0.000557	0.00243	CcSEcCtD
Bismuth Subsalicylate—Oedema—Pamidronate—osteoporosis	0.000553	0.00241	CcSEcCtD
Bismuth Subsalicylate—Infection—Pamidronate—osteoporosis	0.000549	0.00239	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Calcitriol—osteoporosis	0.000549	0.00239	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Estradiol—osteoporosis	0.000548	0.00238	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Calcitriol—osteoporosis	0.000546	0.00238	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Etidronic acid—osteoporosis	0.000541	0.00235	CcSEcCtD
Bismuth Subsalicylate—Rash—Etidronic acid—osteoporosis	0.000536	0.00233	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Etidronic acid—osteoporosis	0.000536	0.00233	CcSEcCtD
Bismuth Subsalicylate—Headache—Etidronic acid—osteoporosis	0.000533	0.00232	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Pamidronate—osteoporosis	0.000527	0.00229	CcSEcCtD
Bismuth Subsalicylate—TF—Hemostasis—RAP1A—osteoporosis	0.000522	0.00344	CbGpPWpGaD
Bismuth Subsalicylate—Pruritus—Estropipate—osteoporosis	0.00052	0.00227	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Estradiol—osteoporosis	0.000518	0.00225	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Alendronate—osteoporosis	0.000513	0.00223	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Risedronate—osteoporosis	0.000512	0.00223	CcSEcCtD
Bismuth Subsalicylate—TF—Platelet degranulation—TGFB1—osteoporosis	0.000511	0.00337	CbGpPWpGaD
Bismuth Subsalicylate—Tinnitus—Estradiol—osteoporosis	0.000511	0.00222	CcSEcCtD
Bismuth Subsalicylate—Constipation—Ethinyl Estradiol—osteoporosis	0.00051	0.00222	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Zoledronate—osteoporosis	0.000509	0.00222	CcSEcCtD
Bismuth Subsalicylate—PTGS2—C-MYB transcription factor network—COL1A2—osteoporosis	0.000507	0.00335	CbGpPWpGaD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—IL6R—osteoporosis	0.000507	0.00334	CbGpPWpGaD
Bismuth Subsalicylate—Nausea—Etidronic acid—osteoporosis	0.000505	0.0022	CcSEcCtD
Bismuth Subsalicylate—Oedema—Zoledronate—osteoporosis	0.000505	0.0022	CcSEcCtD
Bismuth Subsalicylate—ALB—Platelet degranulation—TLN1—osteoporosis	0.000504	0.00333	CbGpPWpGaD
Bismuth Subsalicylate—Diarrhoea—Estropipate—osteoporosis	0.000503	0.00219	CcSEcCtD
Bismuth Subsalicylate—Infection—Zoledronate—osteoporosis	0.000502	0.00218	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Ibandronate—osteoporosis	0.000499	0.00217	CcSEcCtD
Bismuth Subsalicylate—ALB—Platelet degranulation—VCL—osteoporosis	0.000498	0.00328	CbGpPWpGaD
Bismuth Subsalicylate—Constipation—Risedronate—osteoporosis	0.000497	0.00216	CcSEcCtD
Bismuth Subsalicylate—Pain—Risedronate—osteoporosis	0.000497	0.00216	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Arachidonic acid metabolism—GPX1—osteoporosis	0.000496	0.00327	CbGpPWpGaD
Bismuth Subsalicylate—Diarrhoea—Alendronate—osteoporosis	0.000496	0.00216	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000491	0.00214	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Pamidronate—osteoporosis	0.000491	0.00214	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Calcitriol—osteoporosis	0.000489	0.00213	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Raloxifene—osteoporosis	0.000488	0.00212	CcSEcCtD
Bismuth Subsalicylate—TF—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoporosis	0.000487	0.00321	CbGpPWpGaD
Bismuth Subsalicylate—Dyspepsia—Pamidronate—osteoporosis	0.000486	0.00212	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Estropipate—osteoporosis	0.000486	0.00212	CcSEcCtD
Bismuth Subsalicylate—Oedema—Conjugated Estrogens—osteoporosis	0.000486	0.00212	CcSEcCtD
Bismuth Subsalicylate—Infection—Conjugated Estrogens—osteoporosis	0.000483	0.0021	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Ibandronate—osteoporosis	0.000483	0.0021	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Zoledronate—osteoporosis	0.000481	0.00209	CcSEcCtD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—TLN1—osteoporosis	0.000481	0.00317	CbGpPWpGaD
Bismuth Subsalicylate—Decreased appetite—Pamidronate—osteoporosis	0.00048	0.00209	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Alendronate—osteoporosis	0.000479	0.00209	CcSEcCtD
Bismuth Subsalicylate—Erythema—Estradiol—osteoporosis	0.000477	0.00207	CcSEcCtD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—VCL—osteoporosis	0.000474	0.00313	CbGpPWpGaD
Bismuth Subsalicylate—Urticaria—Ethinyl Estradiol—osteoporosis	0.000474	0.00206	CcSEcCtD
Bismuth Subsalicylate—TF—Hemostasis—FGA—osteoporosis	0.000473	0.00312	CbGpPWpGaD
Bismuth Subsalicylate—Constipation—Pamidronate—osteoporosis	0.000473	0.00206	CcSEcCtD
Bismuth Subsalicylate—Pain—Pamidronate—osteoporosis	0.000473	0.00206	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Calcitriol—osteoporosis	0.000472	0.00206	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000471	0.00205	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Raloxifene—osteoporosis	0.000471	0.00205	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Estropipate—osteoporosis	0.000468	0.00204	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Estradiol—osteoporosis	0.000467	0.00203	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Ibandronate—osteoporosis	0.000466	0.00203	CcSEcCtD
Bismuth Subsalicylate—Rash—Estropipate—osteoporosis	0.000464	0.00202	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Estropipate—osteoporosis	0.000463	0.00202	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Conjugated Estrogens—osteoporosis	0.000463	0.00202	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Risedronate—osteoporosis	0.000462	0.00201	CcSEcCtD
Bismuth Subsalicylate—Headache—Estropipate—osteoporosis	0.000461	0.00201	CcSEcCtD
Bismuth Subsalicylate—PTGS2—C-MYB transcription factor network—WNT1—osteoporosis	0.000461	0.00304	CbGpPWpGaD
Bismuth Subsalicylate—Vomiting—Alendronate—osteoporosis	0.000461	0.002	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Risedronate—osteoporosis	0.00046	0.002	CcSEcCtD
Bismuth Subsalicylate—Rash—Alendronate—osteoporosis	0.000457	0.00199	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Alendronate—osteoporosis	0.000456	0.00199	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Pamidronate—osteoporosis	0.000455	0.00198	CcSEcCtD
Bismuth Subsalicylate—Headache—Alendronate—osteoporosis	0.000454	0.00198	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Raloxifene—osteoporosis	0.000453	0.00197	CcSEcCtD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—WDR1—osteoporosis	0.000452	0.00298	CbGpPWpGaD
Bismuth Subsalicylate—Rash—Raloxifene—osteoporosis	0.000449	0.00196	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Raloxifene—osteoporosis	0.000449	0.00195	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Zoledronate—osteoporosis	0.000449	0.00195	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Ibandronate—osteoporosis	0.000449	0.00195	CcSEcCtD
Bismuth Subsalicylate—Headache—Raloxifene—osteoporosis	0.000446	0.00194	CcSEcCtD
Bismuth Subsalicylate—Rash—Ibandronate—osteoporosis	0.000445	0.00194	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Ibandronate—osteoporosis	0.000444	0.00193	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Zoledronate—osteoporosis	0.000444	0.00193	CcSEcCtD
Bismuth Subsalicylate—Headache—Ibandronate—osteoporosis	0.000442	0.00192	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Calcitriol—osteoporosis	0.000439	0.00191	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Zoledronate—osteoporosis	0.000439	0.00191	CcSEcCtD
Bismuth Subsalicylate—Nausea—Estropipate—osteoporosis	0.000437	0.0019	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Pamidronate—osteoporosis	0.000437	0.0019	CcSEcCtD
Bismuth Subsalicylate—Rash—Calcitriol—osteoporosis	0.000435	0.00189	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Calcitriol—osteoporosis	0.000435	0.00189	CcSEcCtD
Bismuth Subsalicylate—Headache—Calcitriol—osteoporosis	0.000433	0.00188	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Conjugated Estrogens—osteoporosis	0.000432	0.00188	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Biological oxidations—CYP27A1—osteoporosis	0.000432	0.00285	CbGpPWpGaD
Bismuth Subsalicylate—Constipation—Zoledronate—osteoporosis	0.000432	0.00188	CcSEcCtD
Bismuth Subsalicylate—Pain—Zoledronate—osteoporosis	0.000432	0.00188	CcSEcCtD
Bismuth Subsalicylate—TF—Hemostasis—FGB—osteoporosis	0.000431	0.00284	CbGpPWpGaD
Bismuth Subsalicylate—Nausea—Alendronate—osteoporosis	0.00043	0.00187	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—osteoporosis	0.00043	0.00283	CbGpPWpGaD
Bismuth Subsalicylate—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000428	0.00186	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Overview of nanoparticle effects—TNF—osteoporosis	0.000428	0.00282	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000427	0.00282	CbGpPWpGaD
Bismuth Subsalicylate—Nausea—Raloxifene—osteoporosis	0.000423	0.00184	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000423	0.00184	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Ethinyl Estradiol—osteoporosis	0.000422	0.00184	CcSEcCtD
Bismuth Subsalicylate—Nausea—Ibandronate—osteoporosis	0.000419	0.00182	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Zoledronate—osteoporosis	0.000416	0.00181	CcSEcCtD
Bismuth Subsalicylate—Constipation—Conjugated Estrogens—osteoporosis	0.000416	0.00181	CcSEcCtD
Bismuth Subsalicylate—Pain—Conjugated Estrogens—osteoporosis	0.000416	0.00181	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Risedronate—osteoporosis	0.000411	0.00179	CcSEcCtD
Bismuth Subsalicylate—Nausea—Calcitriol—osteoporosis	0.00041	0.00179	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000408	0.00178	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Zoledronate—osteoporosis	0.000401	0.00175	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Zoledronate—osteoporosis	0.000399	0.00174	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Risedronate—osteoporosis	0.000398	0.00173	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Ethinyl Estradiol—osteoporosis	0.000394	0.00172	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Arachidonic acid metabolism—GPX1—osteoporosis	0.000394	0.0026	CbGpPWpGaD
Bismuth Subsalicylate—Confusional state—Estradiol—osteoporosis	0.000392	0.00171	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Pamidronate—osteoporosis	0.000391	0.0017	CcSEcCtD
Bismuth Subsalicylate—Oedema—Estradiol—osteoporosis	0.000389	0.00169	CcSEcCtD
Bismuth Subsalicylate—Infection—Estradiol—osteoporosis	0.000386	0.00168	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Conjugated Estrogens—osteoporosis	0.000386	0.00168	CcSEcCtD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—IL1B—osteoporosis	0.000386	0.00254	CbGpPWpGaD
Bismuth Subsalicylate—Dizziness—Risedronate—osteoporosis	0.000384	0.00167	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000384	0.00167	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Ethinyl Estradiol—osteoporosis	0.000379	0.00165	CcSEcCtD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—IGF1—osteoporosis	0.000378	0.00249	CbGpPWpGaD
Bismuth Subsalicylate—Diarrhoea—Pamidronate—osteoporosis	0.000378	0.00165	CcSEcCtD
Bismuth Subsalicylate—ALB—Platelet degranulation—FGA—osteoporosis	0.000377	0.00249	CbGpPWpGaD
Bismuth Subsalicylate—Rash—Ethinyl Estradiol—osteoporosis	0.000376	0.00164	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000376	0.00163	CcSEcCtD
Bismuth Subsalicylate—Headache—Ethinyl Estradiol—osteoporosis	0.000374	0.00163	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Risedronate—osteoporosis	0.00037	0.00161	CcSEcCtD
Bismuth Subsalicylate—Rash—Risedronate—osteoporosis	0.000367	0.0016	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Risedronate—osteoporosis	0.000366	0.00159	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Pamidronate—osteoporosis	0.000365	0.00159	CcSEcCtD
Bismuth Subsalicylate—Headache—Risedronate—osteoporosis	0.000364	0.00158	CcSEcCtD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—FGA—osteoporosis	0.000359	0.00237	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—CAP1—osteoporosis	0.000357	0.00236	CbGpPWpGaD
Bismuth Subsalicylate—Pruritus—Zoledronate—osteoporosis	0.000357	0.00155	CcSEcCtD
Bismuth Subsalicylate—Nausea—Ethinyl Estradiol—osteoporosis	0.000354	0.00154	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Pamidronate—osteoporosis	0.000351	0.00153	CcSEcCtD
Bismuth Subsalicylate—Rash—Pamidronate—osteoporosis	0.000348	0.00152	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Pamidronate—osteoporosis	0.000348	0.00152	CcSEcCtD
Bismuth Subsalicylate—Headache—Pamidronate—osteoporosis	0.000346	0.00151	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Estradiol—osteoporosis	0.000346	0.00151	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Zoledronate—osteoporosis	0.000345	0.0015	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Aryl Hydrocarbon Receptor—ESR1—osteoporosis	0.000345	0.00228	CbGpPWpGaD
Bismuth Subsalicylate—Nausea—Risedronate—osteoporosis	0.000345	0.0015	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Overview of nanoparticle effects—IL6—osteoporosis	0.000345	0.00228	CbGpPWpGaD
Bismuth Subsalicylate—Pruritus—Conjugated Estrogens—osteoporosis	0.000344	0.0015	CcSEcCtD
Bismuth Subsalicylate—ALB—Platelet degranulation—FGB—osteoporosis	0.000343	0.00226	CbGpPWpGaD
Bismuth Subsalicylate—Dyspepsia—Estradiol—osteoporosis	0.000342	0.00149	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Overview of nanoparticle effects—TNF—osteoporosis	0.000339	0.00224	CbGpPWpGaD
Bismuth Subsalicylate—Decreased appetite—Estradiol—osteoporosis	0.000338	0.00147	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Zoledronate—osteoporosis	0.000334	0.00145	CcSEcCtD
Bismuth Subsalicylate—Pain—Estradiol—osteoporosis	0.000333	0.00145	CcSEcCtD
Bismuth Subsalicylate—Constipation—Estradiol—osteoporosis	0.000333	0.00145	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000333	0.00145	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—SOD2—osteoporosis	0.000331	0.00218	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—SOD2—osteoporosis	0.000329	0.00217	CbGpPWpGaD
Bismuth Subsalicylate—Nausea—Pamidronate—osteoporosis	0.000328	0.00143	CcSEcCtD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—FGB—osteoporosis	0.000327	0.00216	CbGpPWpGaD
Bismuth Subsalicylate—Dizziness—Conjugated Estrogens—osteoporosis	0.000321	0.0014	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Zoledronate—osteoporosis	0.000321	0.0014	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Estradiol—osteoporosis	0.000321	0.0014	CcSEcCtD
Bismuth Subsalicylate—Rash—Zoledronate—osteoporosis	0.000318	0.00139	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Zoledronate—osteoporosis	0.000318	0.00138	CcSEcCtD
Bismuth Subsalicylate—Headache—Zoledronate—osteoporosis	0.000316	0.00138	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—GPX1—osteoporosis	0.000316	0.00208	CbGpPWpGaD
Bismuth Subsalicylate—Vomiting—Conjugated Estrogens—osteoporosis	0.000309	0.00134	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Estradiol—osteoporosis	0.000309	0.00134	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Estradiol—osteoporosis	0.000308	0.00134	CcSEcCtD
Bismuth Subsalicylate—Rash—Conjugated Estrogens—osteoporosis	0.000306	0.00133	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Conjugated Estrogens—osteoporosis	0.000306	0.00133	CcSEcCtD
Bismuth Subsalicylate—Headache—Conjugated Estrogens—osteoporosis	0.000305	0.00133	CcSEcCtD
Bismuth Subsalicylate—Nausea—Zoledronate—osteoporosis	0.0003	0.0013	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—MTHFR—osteoporosis	0.000291	0.00192	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—MTHFR—osteoporosis	0.000289	0.00191	CbGpPWpGaD
Bismuth Subsalicylate—Nausea—Conjugated Estrogens—osteoporosis	0.000289	0.00126	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000289	0.0019	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—MGLL—osteoporosis	0.000284	0.00187	CbGpPWpGaD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—TNF—osteoporosis	0.00028	0.00184	CbGpPWpGaD
Bismuth Subsalicylate—Pruritus—Estradiol—osteoporosis	0.000275	0.0012	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Overview of nanoparticle effects—IL6—osteoporosis	0.000274	0.00181	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000274	0.0018	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—SOD2—osteoporosis	0.000268	0.00176	CbGpPWpGaD
Bismuth Subsalicylate—Diarrhoea—Estradiol—osteoporosis	0.000266	0.00116	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—SOD2—osteoporosis	0.000263	0.00173	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—PLEK—osteoporosis	0.00026	0.00171	CbGpPWpGaD
Bismuth Subsalicylate—Dizziness—Estradiol—osteoporosis	0.000257	0.00112	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000257	0.00169	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	0.000256	0.00169	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—GPX1—osteoporosis	0.000255	0.00168	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—GPX1—osteoporosis	0.000251	0.00165	CbGpPWpGaD
Bismuth Subsalicylate—Vomiting—Estradiol—osteoporosis	0.000247	0.00108	CcSEcCtD
Bismuth Subsalicylate—Rash—Estradiol—osteoporosis	0.000245	0.00107	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Estradiol—osteoporosis	0.000245	0.00107	CcSEcCtD
Bismuth Subsalicylate—Headache—Estradiol—osteoporosis	0.000244	0.00106	CcSEcCtD
Bismuth Subsalicylate—TF—Transmembrane transport of small molecules—ADCY5—osteoporosis	0.000239	0.00157	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—MTHFR—osteoporosis	0.000236	0.00155	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—osteoporosis	0.000233	0.00154	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—WDR1—osteoporosis	0.000233	0.00154	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—MTHFR—osteoporosis	0.000231	0.00153	CbGpPWpGaD
Bismuth Subsalicylate—Nausea—Estradiol—osteoporosis	0.000231	0.00101	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000229	0.00151	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Biological oxidations—CYP19A1—osteoporosis	0.000227	0.0015	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	0.000227	0.0015	CbGpPWpGaD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—IL6—osteoporosis	0.000226	0.00149	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—TLN1—osteoporosis	0.000224	0.00148	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—VCL—osteoporosis	0.000221	0.00146	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000217	0.00143	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000213	0.0014	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—SOD2—osteoporosis	0.000213	0.0014	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000207	0.00137	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—GPX1—osteoporosis	0.000203	0.00134	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—IGF1—osteoporosis	0.000195	0.00129	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—MTHFR—osteoporosis	0.000187	0.00123	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000185	0.00122	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—RAP1A—osteoporosis	0.000184	0.00122	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—CAP1—osteoporosis	0.000184	0.00121	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	0.000182	0.0012	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	0.00018	0.00118	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000176	0.00116	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—IL1B—osteoporosis	0.000173	0.00114	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—IL1B—osteoporosis	0.000172	0.00113	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—LEP—osteoporosis	0.00017	0.00112	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000169	0.00111	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	0.000167	0.0011	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—FGA—osteoporosis	0.000167	0.0011	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000166	0.00109	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000165	0.00109	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—osteoporosis	0.000157	0.00103	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet degranulation—IGF1—osteoporosis	0.000155	0.00102	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—FGB—osteoporosis	0.000152	0.001	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—osteoporosis	0.000148	0.000976	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—MGLL—osteoporosis	0.000146	0.000965	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000141	0.00093	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—IL1B—osteoporosis	0.00014	0.000922	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—IL1B—osteoporosis	0.000137	0.000905	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000137	0.000901	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Biological oxidations—POMC—osteoporosis	0.000136	0.000899	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—ANXA2—osteoporosis	0.000134	0.000882	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PLEK—osteoporosis	0.000134	0.000882	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000133	0.000878	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000132	0.000868	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—FDPS—osteoporosis	0.000129	0.000848	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PKM—osteoporosis	0.000129	0.000848	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—TNF—osteoporosis	0.000125	0.000827	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—TNF—osteoporosis	0.000125	0.000822	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PGLS—osteoporosis	0.000122	0.000804	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GPD2—osteoporosis	0.000122	0.000804	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PKM—osteoporosis	0.000122	0.000804	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—SOST—osteoporosis	0.000122	0.000804	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—TGFB1—osteoporosis	0.000117	0.000771	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000116	0.000764	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—ANTXR2—osteoporosis	0.000116	0.000762	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PGLS—osteoporosis	0.000116	0.000762	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—TLN1—osteoporosis	0.000115	0.000761	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—VCL—osteoporosis	0.000114	0.00075	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000112	0.000738	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ATIC—osteoporosis	0.000111	0.000735	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PNP—osteoporosis	0.000111	0.000735	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—IL1B—osteoporosis	0.000111	0.000732	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—C-MYB transcription factor network—MYC—osteoporosis	0.000111	0.000732	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	0.000111	0.000729	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—IL1B—osteoporosis	0.000109	0.000716	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000106	0.000702	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—FDPS—osteoporosis	0.000102	0.000673	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PKM—osteoporosis	0.000102	0.000673	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—TNF—osteoporosis	0.000101	0.000669	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—IL6—osteoporosis	0.000101	0.000668	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—IL6—osteoporosis	0.000101	0.000663	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—TNF—osteoporosis	9.96e-05	0.000657	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—GSN—osteoporosis	9.82e-05	0.000648	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PGLS—osteoporosis	9.67e-05	0.000638	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GPD2—osteoporosis	9.67e-05	0.000638	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	9.57e-05	0.000631	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—RAP1A—osteoporosis	9.51e-05	0.000627	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—OXCT1—osteoporosis	9.48e-05	0.000625	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CA2—osteoporosis	9.48e-05	0.000625	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet degranulation—TGFB1—osteoporosis	9.31e-05	0.000614	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—MGLL—osteoporosis	9.24e-05	0.000609	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	9.05e-05	0.000597	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoporosis	8.87e-05	0.000585	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ATIC—osteoporosis	8.85e-05	0.000584	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PNP—osteoporosis	8.85e-05	0.000584	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	8.71e-05	0.000574	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—FGA—osteoporosis	8.62e-05	0.000569	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—LRP5—osteoporosis	8.54e-05	0.000564	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—MYC—osteoporosis	8.46e-05	0.000558	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—TGFB1—osteoporosis	8.43e-05	0.000556	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PKM—osteoporosis	8.26e-05	0.000544	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—FDPS—osteoporosis	8.26e-05	0.000544	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—IL6—osteoporosis	8.18e-05	0.00054	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—LRP6—osteoporosis	8.17e-05	0.000539	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—TNF—osteoporosis	8.06e-05	0.000531	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—IL6—osteoporosis	8.04e-05	0.00053	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—TNF—osteoporosis	7.88e-05	0.000519	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—IDH2—osteoporosis	7.85e-05	0.000518	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—RPL24—osteoporosis	7.85e-05	0.000518	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—LTF—osteoporosis	7.85e-05	0.000518	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—FGB—osteoporosis	7.84e-05	0.000517	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PGLS—osteoporosis	7.83e-05	0.000516	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GPD2—osteoporosis	7.83e-05	0.000516	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—OXCT1—osteoporosis	7.52e-05	0.000496	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CA2—osteoporosis	7.52e-05	0.000496	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CYP27A1—osteoporosis	7.38e-05	0.000487	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—MGLL—osteoporosis	7.33e-05	0.000484	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ACP5—osteoporosis	7.18e-05	0.000474	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ATIC—osteoporosis	7.16e-05	0.000472	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PNP—osteoporosis	7.16e-05	0.000472	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	7.09e-05	0.000468	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	6.91e-05	0.000456	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—IGF1—osteoporosis	6.89e-05	0.000454	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—ACP5—osteoporosis	6.81e-05	0.000449	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—TPI1—osteoporosis	6.68e-05	0.00044	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—IL6—osteoporosis	6.5e-05	0.000429	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—IL6—osteoporosis	6.36e-05	0.000419	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—TPI1—osteoporosis	6.33e-05	0.000417	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—P4HB—osteoporosis	6.28e-05	0.000414	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—IDH2—osteoporosis	6.23e-05	0.000411	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GAPDH—osteoporosis	6.16e-05	0.000406	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—OXCT1—osteoporosis	6.09e-05	0.000401	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CA2—osteoporosis	6.09e-05	0.000401	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—RAP1A—osteoporosis	6e-05	0.000396	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—P4HB—osteoporosis	5.95e-05	0.000392	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—MGLL—osteoporosis	5.93e-05	0.000391	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CYP27A1—osteoporosis	5.86e-05	0.000387	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—GAPDH—osteoporosis	5.84e-05	0.000385	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	5.75e-05	0.000379	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	5.74e-05	0.000378	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ACP5—osteoporosis	5.7e-05	0.000376	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	5.63e-05	0.000371	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	5.59e-05	0.000369	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—NFATC1—osteoporosis	5.55e-05	0.000366	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—DKK1—osteoporosis	5.51e-05	0.000363	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	5.36e-05	0.000353	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—WNT1—osteoporosis	5.3e-05	0.00035	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—TPI1—osteoporosis	5.3e-05	0.00035	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	5.23e-05	0.000345	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—FGA—osteoporosis	5.16e-05	0.00034	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—IDH2—osteoporosis	5.04e-05	0.000333	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—P4HB—osteoporosis	4.98e-05	0.000329	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GAPDH—osteoporosis	4.89e-05	0.000323	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ENO1—osteoporosis	4.85e-05	0.00032	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PSMA5—osteoporosis	4.78e-05	0.000315	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PSMA2—osteoporosis	4.78e-05	0.000315	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—RAP1A—osteoporosis	4.76e-05	0.000314	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CYP27A1—osteoporosis	4.74e-05	0.000313	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ACP5—osteoporosis	4.61e-05	0.000304	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—ENO1—osteoporosis	4.6e-05	0.000303	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	4.55e-05	0.0003	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PSMA2—osteoporosis	4.53e-05	0.000299	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PSMA5—osteoporosis	4.53e-05	0.000299	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—ADCY5—osteoporosis	4.35e-05	0.000287	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—TPI1—osteoporosis	4.29e-05	0.000283	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CALCA—osteoporosis	4.22e-05	0.000278	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	4.15e-05	0.000274	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	4.13e-05	0.000272	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—P4HB—osteoporosis	4.03e-05	0.000266	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GAPDH—osteoporosis	3.96e-05	0.000261	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CYP19A1—osteoporosis	3.88e-05	0.000256	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—RAP1A—osteoporosis	3.85e-05	0.000254	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ENO1—osteoporosis	3.85e-05	0.000254	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—KL—osteoporosis	3.83e-05	0.000253	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PSMA2—osteoporosis	3.79e-05	0.00025	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PSMA5—osteoporosis	3.79e-05	0.00025	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—IGF1—osteoporosis	3.55e-05	0.000234	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.36e-05	0.000222	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ADCY5—osteoporosis	3.17e-05	0.000209	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GPX1—osteoporosis	3.16e-05	0.000208	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ENO1—osteoporosis	3.12e-05	0.000205	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CYP19A1—osteoporosis	3.08e-05	0.000203	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PSMA2—osteoporosis	3.07e-05	0.000202	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PSMA5—osteoporosis	3.07e-05	0.000202	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—ADCY5—osteoporosis	3e-05	0.000198	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—MTHFR—osteoporosis	2.91e-05	0.000192	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—MTHFR—osteoporosis	2.76e-05	0.000182	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—IRS2—osteoporosis	2.63e-05	0.000173	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ADCY5—osteoporosis	2.52e-05	0.000166	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GPX1—osteoporosis	2.51e-05	0.000165	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CYP19A1—osteoporosis	2.49e-05	0.000164	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—POMC—osteoporosis	2.33e-05	0.000154	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—MTHFR—osteoporosis	2.31e-05	0.000153	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—IRS1—osteoporosis	2.29e-05	0.000151	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—IL6R—osteoporosis	2.16e-05	0.000142	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—TGFB1—osteoporosis	2.13e-05	0.00014	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ADCY5—osteoporosis	2.04e-05	0.000134	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GPX1—osteoporosis	2.03e-05	0.000134	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—MTHFR—osteoporosis	1.87e-05	0.000123	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—POMC—osteoporosis	1.85e-05	0.000122	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—POMC—osteoporosis	1.5e-05	9.87e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—MYC—osteoporosis	1.28e-05	8.42e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—TGFB1—osteoporosis	1.27e-05	8.4e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—IL6—osteoporosis	9.6e-06	6.33e-05	CbGpPWpGaD
